The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Heron Therapeutics, Inc(NASDAQ:HRTX) 
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents o...
Website: http://www.herontx.com
Founded: 1983
Full Time Employees: 231
Sector: Healthcare
Industry: Biotechnology
Heron Therapeutics Days Payable Outstanding ttm (DPO)
Heron Therapeutics Days Receivable Outstanding ttm (DSO)
Heron Therapeutics Days Inventory Outstanding ttm (DIO)
Heron Therapeutics Op Cashflow Per Share ttm
Heron Therapeutics Free Cashflow Per Share ttm
Heron Therapeutics Cash Per Share ttm
Heron Therapeutics P/S ratio ttm
Heron Therapeutics (GAAP) P/E ratio ttm
Heron Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.